Literature DB >> 32437864

Immune Checkpoint Inhibitor-Associated Optic Neuritis.

Jasmine H Francis1, Korey Jaben2, Bianca D Santomasso3, Julia Canestraro4, David H Abramson2, Paul B Chapman5, Meghan Berkenstock6, Mary E Aronow7.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32437864     DOI： 10.1016/j.ophtha.2020.05.003

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  5 in total

1.  Clinical Reasoning: A 48-year-old Woman With 6 Months of Vivid Visual Hallucinations.

Authors:  Jennifer Kizza; Richard J Lu; Jonah Zuflacht; Marc Bouffard
Journal:  Neurology       Date:  2022-05-16       Impact factor: 11.800

Review 2.  Ocular Toxicity of Targeted Anticancer Agents.

Authors:  Blake H Fortes; Prashant D Tailor; Lauren A Dalvin
Journal:  Drugs       Date:  2021-03-31       Impact factor: 9.546

Review 3.  Neuro-ophthalmic Complications of Immune Checkpoint Inhibitors: A Systematic Review.

Authors:  Caberry W Yu; Matthew Yau; Natalie Mezey; Ishraq Joarder; Jonathan A Micieli
Journal:  Eye Brain       Date:  2020-11-03

4.  Anti-PD-1 sintilimab-induced bilateral optic neuropathy in non-small cell lung cancer: A case report and literature review.

Authors:  Jian Wang; Xiaoyue Xiao; Xiaorong Dong; Gang Wu; Xinghua Wang; Ruiguang Zhang
Journal:  Front Oncol       Date:  2022-08-09       Impact factor: 5.738

5.  Immune checkpoint inhibitor associated ocular hypertension (from presumed trabeculitis).

Authors:  Julia Canestraro; Anna Do; Seth D Potash; Joseph Panarelli; Meghan Berkenstock; David H Abramson; Jasmine H Francis
Journal:  Am J Ophthalmol Case Rep       Date:  2021-05-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.